Cannell & Spears LLC

Position in FTRE — Fortrea Holdings Inc.

CIK 1426319 NEW YORK, NY

Position in FTRE

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$544,881

+$249,894 QoQ

Shares Held

31,315

0.0% QoQ

Ownership

0.033%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#127

of 334 holders

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Cannell & Spears LLC holds $44,689,983 across 5 Biotechnology names. FTRE ranks #4 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	36,099	$22,509,170
2	AXSM	Axsome Therapeutics, Inc.	84,154	$20,598,374
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,966	$976,571
4	FTRE	Fortrea Holdings Inc. This page	31,315	$544,881
5	ALEC	Alector, Inc.	30,342	$60,987

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$544,881	31,315	0.0%	Shares	Sole	2026-08-11
2026-03-31	$294,987	31,315	0.0%	Shares	Sole	2026-05-15
2025-12-31	$540,183	31,315	+184.3%	Shares	Sole	2026-02-17
2025-06-30	$54,409	11,014	-34.2%	Shares	Sole	2025-08-14
2025-03-31	$126,447	16,748	0.0%	Shares	Sole	2025-05-14
2024-12-31	$312,350	16,748	-26.9%	Shares	Sole	2025-02-12
2024-09-30	$458,500	22,925	-0.9%	Shares	Sole	2024-11-12
2024-06-30	$540,064	23,139	-3.3%	Shares	Sole	2024-08-12
2024-03-31	$960,911	23,939	—	Shares	Sole	2024-05-10
No filing history on record for this holder in this stock.